日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tucatinib-trastuzumab-capecitabine for treatment of leptomeningeal metastasis in women with HER2(+) breast cancer: TBCRC049 phase 2 study results

Tucatinib-trastuzumab-capecitabine治疗HER2(+)乳腺癌女性软脑膜转移:TBCRC049 II期研究结果

Murthy, Rashmi K; O'Brien, Barbara J; Berry, Donald A; Singareeka-Raghavendra, Akshara; Monroe, Maria Gule; Johnson, Jason; White, Jason; Schwartz-Gomez, Jill; Topletz-Erickson, Ariel; Lobbous, Mina; Riley, Kristen; Melisko, Michelle; Morikawa, Aki; Ferguson, Sherise D; de Groot, John F; Krop, Ian E; Valero, Vicente; Rimawi, Mothaffar F; Wolff, Antonio C; Tripathy, Debu; Lin, Nancy U; Stringer-Reasor, Erica M

PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical Models.

PI3Kα抑制剂和降解剂Inavolisib可利用FGFR2增强PIK3CA突变实体瘤患者和临床前模型的疗效。

Juric Dejan, Song Kyung, Johnson Radia M, Accordino Melissa K, Bedard Philippe L, Cervantes Andrés, Gambardella Valentina, Hamilton Erika, Italiano Antoine, Kalinsky Kevin, Krop Ian E, Oliveira Mafalda, Saura Cristina, Schmid Peter, Turner Nicholas C, Varga Andreea, Gendreau Steven, Hwang Michael S, Kuang Zheng, Lau Jeffrey T, Lin Eva, Pham Trang, Maddalo Danilo, Rees Matthew G, Ronan Melissa M, Roth Jennifer A, Martin Scott, Sodir Nicole M, Sokol Ethan S, Whitfield Zachary J, Wong Alice, Yauch Robert L, Aimi Junko, Cheeti Sravanthi, Fredrickson Jill, Hilz Stephanie, Hafner Marc, Hutchinson Katherine E, Jin Yanling, Peters Ubong, Zingg Daniel, Royer-Joo Stephanie, Shankar Noopur, Schutzman Jennifer L, Jhaveri Komal L, Dey Anwesha

Correction: Stroma-driven horizontal transfer of TCA-related proteins mediates metabolic plasticity and Imatinib resistance in chronic myeloid leukemia

更正:基质驱动的TCA相关蛋白水平转移介导慢性粒细胞白血病的代谢可塑性和伊马替尼耐药性

Chroscicki, Piotr; Kasak, Nikodem; Dymkowska, Dorota; Turos-Korgul, Laura; Cysewski, Dominik; Chumak, Vira; Stepnik, Dawid; Kusio-Kobialka, Monika; Kominek, Agata; Lebiedzinska-Arciszewska, Magdalena; Krop, Alicja; Szczepanowska, Joanna; Wieckowski, Mariusz; Stoklosa, Tomasz; Zablocki, Krzysztof; Piwocka, Katarzyna

TBCRC 035: randomized phase II pharmacodynamic study of standard and reduced-dose palbociclib with endocrine therapy in hormone receptor (HR)-positive previously treated metastatic breast cancer

TBCRC 035:一项随机 II 期药效学研究,评估标准剂量和减量帕博西尼联合内分泌治疗在激素受体 (HR) 阳性、既往接受过治疗的转移性乳腺癌患者中的疗效

Jacob, S; Mayer, E L; Kacik, N; Storniolo, A M; Isaacs, C; Mayer, I; Stearns, V; Nanda, R; Nangia, J; Chien, A J; Moasser, M; Melisko, M; Wabl, C; Muzikansky, A; Geradts, J; Dillon, D A; Park, B H; Krop, I; Wolff, A C; Kochupurakkal, B; Shapiro, G I; Rugo, H S

Prognostic value of visually and computationally assessed tumor-infiltrating lymphocytes in early-stage triple-negative breast cancer (TBCRC-030)

视觉和计算机评估的肿瘤浸润淋巴细胞在早期三阴性乳腺癌中的预后价值(TBCRC-030)

Nader-Marta, Guilherme; Chu, Xiangying; Mukhopadhyay, Satabhisa; Abramson, Vandana G; Brufsky, Adam; Stringer-Reasor, Erica Michelle; Dent, Susan Faye; Traina, Tiffany A; Carey, Lisa A; Rimawi, Mothaffar F; Specht, Jennifer M; Miller, Kathy D; Santa-Maria, Cesar Augusto; Dasgupta, Tathagata; Kurt, Busem Binboğa; DeMeo, Michelle; Krop, Ian E; Tung, Nadine M; Schnitt, Stuart J; Tayob, Nabihah; Mayer, Erica L

Myeloid-T cell proximity is prominent in healthy pregnancies with extreme fetal-maternal HLA incompatibility

在胎儿与母体HLA极度不相容的健康妊娠中,髓系细胞与T细胞的接近现象十分显著。

Tian, Xuezi; Krop, Juliette; Ijsselsteijn, Marieke E; Kapsenberg, Johanna M; Anholts, Jacqueline D H; van der Meeren, Lotte; Mei, Hailiang; Huigen, Michiel H J; van der Keur, Carin; Roelen, Dave L; Lashley, Lisa E E L O; van Beelen, Els; Koning, Frits; van der Hoorn, Marie-Louise P; Eikmans, Michael

A phase II study of atezolizumab in combination with stereotactic radiation for patients with triple-negative breast cancer and brain metastasis

一项针对三阴性乳腺癌脑转移患者的阿特珠单抗联合立体定向放射治疗的II期研究

Giordano, Antonio; Graham, Noah; Aizer, Ayal A; Tayob, Nabihah; Pereslete, Alyssa M; Schoenfeld, Jonathan D; Leone, Jose Pablo; Davis, Raechel; Erick, Timothy K; Mayer, Erica L; Winer, Eric P; Krop, Ian; Tolaney, Sara M; Lin, Nancy U

Efficacy, safety, and predictive biomarkers of neoadjuvant nab-paclitaxel and pembrolizumab in hormone receptor-positive breast cancer: A randomized pilot trial

新辅助紫杉醇联合帕博利珠单抗治疗激素受体阳性乳腺癌的疗效、安全性及预测性生物标志物:一项随机试点试验

Waks, Adrienne G; Fu, Jingxin; Chu, Xiangying; Binboga Kurt, Busem; Li, Tianyu; Kuntz, Thomas M; Shen, Yizhuo; Yang, David; Meli, Kevin; Reardon, Brendan; Park, Jihye; Partridge, Ann; Abravanel, Daniel; Jeselsohn, Rinath; Wrabel, Eileen; Alberti, Jillian; DiLullo, Molly; Chen, Serenity; Mohammed-Abreu, Ayesha; Sun, Xiaopeng; Balko, Justin M; Kleijn, Miranda; Audeh, William; Morgan, Xochitl C; Krop, Ian E; Tayob, Nabihah; Van Allen, Eliezer M; Mittendorf, Elizabeth A; Tolaney, Sara M

An in vivo screen identifies NAT10 as a master regulator of brain metastasis

体内筛选发现NAT10是脑转移的关键调控因子

Jocelyn F Chen ,Peng Xu ,Wesley L Cai ,Huacui Chen ,Emily Wingrove ,Xiaojian Shi ,Wenxue Li ,Giulia Biancon ,Meiling Zhang ,Amer Balabaki ,Ethan D Krop ,Elianna Asare ,Yangyi Zhang ,Mingzhu Yin ,Toma Tebaldi ,Jordan L Meier ,Thomas F Westbrook ,Stephanie Halene ,Yansheng Liu ,Hongying Shen ,Don X Nguyen ,Qin Yan

Detection of heterogeneous resistance mechanisms to tyrosine kinase inhibitors from cell-free DNA

从无细胞DNA中检测酪氨酸激酶抑制剂的异质性耐药机制

Parsons, Heather A; Messer, Conor; Santos, Katheryn; Weiss, Jakob; Merrell, David; Danysh, Brian P; Hughes, Melissa E; Kirkner, Gregory J; Patel, Ashka; Hess, Julian; Sendrick, Kerry; Stewart, Chip; Grant, Elizabeth; Schlueter-Kuck, Kristy; Grinshpun, Albert; Wagle, Nikhil; Veeraraghavan, Jamunarani; Leone, Jose Pablo; Freedman, Rachel A; Metzger, Otto; Schiff, Rachel; Winer, Eric P; Tolaney, Sara M; Rimawi, Mothaffar; Krop, Ian E; Getz, Gad; Lin, Nancy U